FdaApplication
NDA 019516
Identifiers
- fda_app_no: NDA019516
Properties
| Property | Value |
|---|---|
| applicant_name | KNOA PHARMA LLC |
| application_type | NDA |
| approval_date | 1987-05-29 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MS CONTIN | MORPHINE SULFATE | 60MG | TABLET, EXTENDED RELEASE;ORAL |
| MS CONTIN | MORPHINE SULFATE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| MS CONTIN | MORPHINE SULFATE | 30MG | TABLET, EXTENDED RELEASE;ORAL |
| MS CONTIN | MORPHINE SULFATE | 15MG | TABLET, EXTENDED RELEASE;ORAL |
| MS CONTIN | MORPHINE SULFATE | 200MG | TABLET, EXTENDED RELEASE;ORAL |
5 products